🔎 Trials Near Me

Akèy › Trombositemi Esansyèl › New York

Etid klinik pou Trombositemi Esansyèl nan New York

7 etid pou Trombositemi Esansyèl ap chèche patisipan nan sit nan New York.

Vil nan New York

Tèks ofisyèl etid la (Anglè)

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

  • NYP/Weill Cornell Medical Center, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06661915

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  • Icahn School of Medicine At Mount Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • Weill Cornell Medical College - Newyork-Presbyterian Hospita, New York
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07623200

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

  • Icahn School of Medicine At Mount Sinai, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  • Memorial Sloan Kettering Cancer Center, New York
  • Mount Sinai School of Medicine, New York
  • Weill Cornell Medicine, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07441694

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

  • Icahn School of Medicine At Mount Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 17, 2026 · NCT06034002

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

  • Memorial Sloan Kettering Cancer Center, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 23, 2026 · NCT07362225

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

  • Ruttenberg Treatment Center, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT06541249

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.